Review of Current Global Evidences for Prevention of Coronary Heart Disease
India is experiencing epidemiologic transition with a sharp increase in coronary heart disease (CHD).
India is experiencing epidemiologic transition with a sharp increase in coronary heart disease (CHD).
Approximately 1% of newborns have congenital heart disease which is responsible for 30%–50% of infant mortality due to birth defects.
Among the factors intervening in the development of cardiovascular pathology, not only at the endothelial coronary level but also at the level of the myocardial syncytium, is also the osteopontin (OPN).
In a survey of 30 different sites in China, Pulse pressure was related positively to atherosclerosis.
LIFE is a multicentre, open-label, prospective, observational study estimating health related QoL and functional endpoints with initiation of Ivabradine in older patients.